There is no single best Korean Botox brand for every practice. Botulax and Nabota are the most established internationally, and their U.S. versions, Letybo and Jeuveau, are FDA-approved. Meditoxin has one of the longest track records in Korea, Coretox and Innotox stand out for their formulations, and Liztox, exported as Hutox, has a growing global footprint. The right choice depends on where you practice, the approved indications in that market, your preferred format, and how well you can verify the supply chain.

“Korean Botox” is shorthand, not a product. BOTOX is a brand name owned by AbbVie’s Allergan. The products below are separate botulinum toxin type A brands made by Korean manufacturers.

Best Korean Botox Brands at a Glance

This table compares the main brands by the details that most affect purchasing. Regulatory status varies by country, so use it as a starting point and confirm the status of the exact product in your market.

BrandManufacturerFormatOther market nameFDA-approved in the U.S.?
BotulaxHugelFreeze-dried powderLetyboYes, as Letybo only
NabotaDaewoong PharmaceuticalFreeze-dried powderJeuveauYes, as Jeuveau only
MeditoxinMedytoxFreeze-dried powderNeuronoxNo
CoretoxMedytoxFreeze-dried powderNone widely usedNo
InnotoxMedytoxReady-to-use liquidNone widely usedNo
LiztoxHuons BioPharmaFreeze-dried powderHutoxNo

The Leading Korean Toxins Compared

Botulax and Letybo

Botulax is made by Hugel and has been on the market since 2009. It is often described as one of South Korea’s top-selling toxins, and it is available in several vial sizes, including 100, 200 and 300 units, depending on the market. In the United States, Hugel’s toxin is sold as Letybo (letibotulinumtoxinA-wlbg), which is supplied in 50-unit and 100-unit vials.

A Korean phase 3 non-inferiority trial compared 20 units of Hugel’s toxin with 20 units of onabotulinumtoxinA for glabellar lines and reported comparable week 4 results. For many buyers, Botulax is the natural first option because of its wide availability and range of vial sizes.

Nabota and Jeuveau

Nabota is made by Daewoong Pharmaceutical. It was the first Korean toxin to reach the U.S. aesthetic market, where it is sold as Jeuveau (prabotulinumtoxinA-xvfs) and marketed by Evolus. Jeuveau comes in a 100-unit vial, while Nabota vial sizes vary by market and can include 50, 100 and 200 units.

Nabota is a strong fit for buyers who value a long regulatory record across multiple countries. Its purity claims vary from one supplier to another, so judge it on its label and clinical data, not on a percentage in a sales listing.

Meditoxin

Meditoxin has been manufactured by Medytox since 2006 and is also known as Neuronox in export markets. It is one of the products that established Korea as a serious toxin producer. It is a traditional freeze-dried type A toxin, usually listed in 100-unit and 200-unit sizes. Practices that prefer a familiar, conventional format often place it on their shortlist.

Coretox

Coretox, also from Medytox, is known for its low-protein approach. The toxin is purified to remove complexing proteins, which puts it in a different formulation category from conventional Korean toxins. It appeals to practitioners who are specifically interested in reducing total protein load, although that benefit should be weighed realistically, as explained below.

Innotox

Innotox, a third Medytox product, is a ready-to-use liquid botulinum toxin. Because it does not need reconstitution, it removes a preparation step that powdered toxins require. Its appeal is workflow convenience rather than a proven difference in results. Innotox is approved in Korea but is not FDA-approved.

Liztox and Hutox

Liztox is made by Huons BioPharma. It is often confused with other brands, and some online sources wrongly attribute it to Hugel. Liztox is approved in Korea in 50, 100 and 200-unit sizes, and the same toxin is exported as Hutox. Huons has expanded the product into a growing number of markets, including China, where it is sold under the Liztox name. When comparing suppliers, treat Liztox and Hutox as related names and check the labeling for your market.

You may also see newer or smaller Korean brands such as Wondertox. Apply the same checks to these products: confirm the manufacturer, local approval and evidence before adding them to your range.

Which Korean Botox Is FDA-Approved?

Two Korean-made toxins are FDA-approved for cosmetic use: Jeuveau, approved in 2019, and Letybo, approved in February 2024. Both are approved for the temporary improvement of moderate-to-severe glabellar lines in adults.

The approval applies to the U.S. product, not to every vial made by the same company. A Letybo approval does not make a Botulax-labeled vial FDA-approved, and a Jeuveau approval does not extend to Nabota-labeled stock. Meditoxin, Coretox, Innotox and Liztox are not FDA-approved. Practitioners outside the U.S. should check their own regulator’s position, because a product that is unapproved in the United States may be fully licensed elsewhere.

Which Korean Botox Lasts the Longest?

No Korean toxin has been proven to last the longest. Comparative research between Korean brands is limited, and most phase 3 trials were designed to show non-inferiority to onabotulinumtoxinA at around week 4, not to rank products by longevity.

Most clinical sources describe a typical duration of about 3 to 4 months, in line with other type A toxins. Claims of 6 months or more appear on some sales and clinic pages, but they should not be treated as a brand standard. Dose, treatment area, muscle strength, patient metabolism, treatment history and injection technique all influence how long results last. Onset is also often advertised at 2 to 4 days, with peak effect arriving later, and these timelines vary by patient.

What Actually Differs Between Korean Toxins

Korean toxins share the same basic mechanism: they temporarily block acetylcholine release at the neuromuscular junction. The practical differences lie in how each product is formulated, handled and labeled.

Freeze-Dried vs Liquid

Most Korean toxins are freeze-dried powders that need reconstitution with sterile saline. This format is familiar and allows the practitioner to adjust dilution within labeled guidance. Liquid toxins such as Innotox skip that step, which can simplify preparation and reduce handling variation. Whichever format you use, follow the product’s own storage instructions and in-use limits. Published post-reconstitution windows differ across products and sources, so the label is the only reliable reference.

Complexing Proteins and Purity

Low-protein formulations are promoted on the idea that less non-toxin protein may reduce the risk of neutralizing antibodies. The theory is reasonable, but evidence that it changes outcomes for routine aesthetic patients is limited. Purity figures such as 99% also appear often in supplier copy, frequently without a stated method or source. Treat these numbers as marketing claims unless they are backed by labeling or published data.

Units Are Not Interchangeable

A unit of one toxin is not the same as a unit of another. Labels state that potency units are product-specific, which means you cannot assume a 1:1 conversion when switching brands. Vial size matters too. A 100-unit vial may suit lower-volume practices, while 200-unit or larger vials can suit busier schedules or larger treatment areas, provided the full vial can be used within the permitted window.

Korean Toxins vs Botox and Dysport

Korean toxins are not copies of BOTOX. They are independently developed type A products, and several have been tested against onabotulinumtoxinA in phase 3 trials for glabellar lines, with comparable short-term results. Their main commercial draw is that they often cost less, although the price gap varies widely by market and supplier.

No Korean toxin is an established equivalent of Dysport. Dysport (abobotulinumtoxinA) has its own unit system and dosing, so its units cannot be transferred directly to any Korean brand. Claims that one Korean product is “closest to Dysport” usually refer to perceived onset or spread rather than a proven match. If you are moving patients from Dysport, plan dosing from the new product’s label and your clinical judgment, not from a conversion chart.

How to Choose a Korean Toxin for Your Practice

Start with what you can legally use, then narrow your options by clinical and commercial fit:

  • Local approval: Confirm that the exact product, name and vial size are authorized in your market.
  • Indication: Check whether the label covers the areas you treat. Glabellar lines are the best-studied use, and approved indications differ by country.
  • Evidence: Prefer brands with published trials for the indications you plan to treat, not just supplier claims.
  • Format: Decide whether you prefer the flexibility of a freeze-dried product or the convenience of a liquid.
  • Vial size: Match units per vial to your patient volume so that you avoid waste.
  • Cold chain and traceability: Ask how the product is stored and shipped, and make sure lot numbers and sealed packaging can be verified.
  • Price per usable unit: Compare cost after allowing for waste and the product’s own dosing, because a lower vial price does not always mean a lower treatment cost.

Once you have a shortlist, you can browse our botulinum toxin range for licensed professionals and compare the brands and vial sizes currently available.

Products by Category

FAQ

What do Koreans use instead of Botox?

In Korea, domestic toxins are widely used alongside imported brands. Botulax, Nabota, Meditoxin and Liztox are all familiar names in the local market, and price and clinic preference often drive the choice.

Can U.S. clinics legally use Botulax or Meditoxin?

No, not as Botulax- or Meditoxin-labeled products. Unapproved foreign toxins should not be used in the United States outside authorized clinical research. U.S. practices looking for a Korean-made toxin should use FDA-approved Jeuveau or Letybo from authorized channels.

Is Korean botulinum toxin safe?

Korean toxins carry the same general risks as other botulinum toxins, and safety depends on an approved product, correct storage and a trained injector. Common effects can include headache, injection-site reactions and eyelid drooping. Like other toxins, they carry a risk of distant spread, and these prescription products are not for self-administration.

Why is Korean toxin often cheaper?

Lower prices usually reflect market factors such as strong domestic competition and regional pricing, not necessarily lower quality. Even so, an unusually low price is a reason to check authenticity, lot traceability and cold-chain handling before you buy.